Jianming Xu, Doctor
Chinese PLA General Hosptial · 301 Hospital of PLA，Beijing，China · Chinese PLA General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jianming Xu, Doctor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06158516 · A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine TumorsChanghai Hospital · terminated · Pancreatic Neuroendocrine Tumor · principal investigator
- Ph1/Ph2NCT04601610 · KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular CarcinomaJiangsu Alphamab Biopharmaceuticals Co., Ltd · terminated · Advanced HCC · principal investigator
- Ph3NCT04415853 · Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerSunshine Lake Pharma Co., Ltd. · recruiting · Esophageal Cancer · principal investigator
- Ph1NCT03356158 · A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal CancerSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph1/Ph2NCT02489201 · A Study of Donafenib Monotherapy in Advanced Oesophageal CancerSuzhou Zelgen Biopharmaceuticals Co.,Ltd · terminated · Oesophageal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.